A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to...

por Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Tuite, Ashleigh, Robbins, Ninette F., Orjuela, Guillermo, Jenkins, Craig, Conrod, Valerie, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Publicado 2022

Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021

por Lin, Yi-Chan J., Evans, David H., Robbins, Ninette F., Orjuela, Guillermo, Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Tuite, Ashleigh, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Publicado 2023

Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses

por Lin, Yi-Chan J., Evans, David H., Robbins, Ninette F., Orjuela, Guillermo, Hu, Queenie, Samson, Reuben, Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Tuite, Ashleigh, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Publicado 2022